1921
Volume 93, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Mass drug administration (MDA) was a component of many malaria programs during the eradication era, but later was seldomly deployed due to concerns regarding efficacy and feasibility and fear of accelerating drug resistance. Recently, however, there has been renewed interest in the role of MDA as an elimination tool. Following a 2013 Cochrane Review that focused on the quantitative effects of malaria MDA, we have conducted a systematic, qualitative review of published, unpublished, and gray literature documenting past MDA experiences. We have also consulted with field experts, using their historical experience to provide an informed, contextual perspective on the role of MDA in malaria elimination. Substantial knowledge gaps remain and more research is necessary, particularly on optimal target population size, methods to improve coverage, and primaquine safety. Despite these gaps, MDA has been used successfully to control and eliminate and malaria in the past, and should be considered as part of a comprehensive malaria elimination strategy in specific settings.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0254
2015-07-08
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/1/125.html?itemId=/content/journals/10.4269/ajtmh.14-0254&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2010. Guidelines for the Treatment of Malaria, 2nd edition. Geneva, Switzerland: World Health Organization.
  2. Feachem RG, Phillips AA, Targett GA, The Malaria Elimination Group, , 2009. Shrinking the Malaria Map: A Prospectus on Malaria Elimination. San Francisco, CA: Global Health Group, UCSF Global Health Sciences.
  3. Shanks GD, , 2012. Control and elimination of Plasmodium vivax . Adv Parasitol 80: 301341.[Crossref]
  4. Von Seidlein L, Greenwood BM, , 2003. Mass administrations of antimalarial drugs. Trends Parasitol 19: 452460.[Crossref]
  5. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J, , 2013. Mass drug administration for malaria. Cochrane Database of Systematic Reviews 12: CD008846.
  6. Newby G, Koita K, Ippolito M, , 2013. MDA Qualtrics Data. The Global Health Group, University of California, San Francisco. Available at: http://globalhealthsciences.ucsf.edu/news-events/malaria-elimination-background-paper-series-and-policy-briefs.
  7. World Health Organization Regional Office for the Western Pacific, 1964. Report of the Third Inter-Territorial Malaria Conference for the South-West Pacific. Honiara, Solomon Islands.
  8. Kondrashin A, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VP, , 2014. Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J 13: 51.[Crossref]
  9. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RGA, Gosling RD, Gao Q, , 2013. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Malar J 12: 383.[Crossref]
  10. The Global Health Group, 2014. Review of Mass Drug Administration and Primaquine Use. Available at: http://globalhealthsciences.ucsf.edu/sites/default/files/content/ghg/mei-review-of-mda-and-primaquine.pdf.
  11. Kligler IJ, Mer G, , 1931. Periodic intermittent treatment with chinoplasmine as a measure of malaria control in a hyperendemic area. Riv Malariol 10: 425438.
  12. Gabaldon A, Guerrero L, , 1959. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am J Trop Med Hyg 8: 433439.
  13. Song J, Socheat D, Tan B, Dara P, Deng C, Sokunthea S, Seila S, Ou F, Jian H, Li G, , 2010. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J 9: 57.[Crossref]
  14. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Björkman A, , 2000. Malaria eradication on islands. Lancet 356: 15601564.[Crossref]
  15. Department of Health, The Executive Yuan Republic of China, 1991. Malaria eradication in Lanyu. Malaria Eradication in Taiwan 245262.
  16. Berberian DA, Dennis EW, , 1948. Field Experiments with chloroquine diphosphate. Am J Trop Med 28: 755776.
  17. Huehne WH, , 1971. Experience with an insecticide/drug combination and observations on suppressive chloroquine/pyrimethamine treatment. J Trop Med Hyg 74: 110116.
  18. Dupoux R, Marini C, Barthas R, , 1937. Results of mass prophylaxis of malaria in Tunis. Bull Acad Med 118: 368372.
  19. Liu YL, Wu KS, Jia JX, , 1986. Integrated approach in malaria control including environmental management to reduce man-mosquito contact and reduction of infection source in Huanghuai Plain. J Parasitol Parasit Dis 4: 246250.
  20. Dapeng L, Leyuan S, Xili L, Xiance Y, , 1996. A successful control programme for falciparum malaria in Xinyang, China. Trans R Soc Trop Med Hyg 90: 100102.[Crossref]
  21. Lakshmanacharyulu T, Guha AK, Kache SR, , 1968. Control of malaria epidemics in a river valley project. Bull Ind Soc for Mal Com 94105.
  22. White LJ, Maude RJ, Pongtavornpinyo W, Saralamba S, Aguas R, Van Effelterre T, Day NPJ, White NJ, , 2009. The role of simple mathematical models in malaria elimination strategy design. Malar J 8: 212.[Crossref]
  23. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, Bousema T, Drakeley CJ, Ghani AC, , 2011. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One 6: e20179.[Crossref]
  24. Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, von Seidlein L, Drakeley C, on behalf of the Primaquine in Africa Discussion Group, , 2012. Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J 11: 360.[Crossref]
  25. White NJ, , 2013. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 13: 175181.[Crossref]
  26. Ashley EA, Recht J, White NJ, , 2014. Primaquine: the risks and the benefits. Mal J 13: 418.[Crossref]
  27. Deen JL, von Seidlein L, Pinder M, Walraven GEL, Greenwood BM, , 2001. The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg 95: 424428.[Crossref]
  28. Von Seidlein L, Walraven G, Milligan PJM, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin S, Olliaro P, Bennett S, van der Loeff MS, Okunoye K, Targett GAT, McAdam KPWJ, Doherty JF, Greenwood BM, Pinder M, , 2003. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg 97: 217225.[Crossref]
  29. Reiner RC, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JRC, Bisanzio D, Buckee C, Chiyaka C, Cummings DAT, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lindsay SW, Lloyd AL, Pigott DM, Reisen WK, Ruktanonchai N, Singh BK, Tatem AJ, Kitron U, Hay SI, Scott TW, Smith DL, , 2013. A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010. J R Soc Interface 10: 20120921.[Crossref]
  30. Singh MV, Agarwala RS, Singh KN, , 1968. Epidemiological study of focal outbreak of malaria in consolidation phase area and evalution of remedial measures in Uttar Pradesh (India). Bull Ind Soc Mal Com 5: 207220.
  31. De Zulueta J, , 1964. A malaria eradication experiment in the highlands of Kigezi (Uganda). East Afr Med J 41: 102120.
  32. Joncour G, , 1956. La Lutte Contre Le Paludisme A Madagascar. Bull World Health Organ 15: 711723.
  33. Ossi GT, , 1967. An epidemic in the life of a malaria eradication programme. Bull Endem Dis (Baghdad) 9: 518.
  34. Dola SK, , 1974. Mass drug administration as a supplementary attack measure in malaria eradication programme. East Afr Med J 51: 529531.
  35. Garfield RM, Vermund SH, , 1983. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet 2: 500503.[Crossref]
  36. Han ET, Lee DH, Park KD, Seok WS, Kim YS, Tsuboi T, Shin EH, Chai JY, , 2006. Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea. Korean J Parasitol 44: 285294.[Crossref]
  37. Aliev SP, , 2000. Malaria in the Republic of Tajikistan. Med Parazitol (Mosk) 2: 2729.
  38. Hii JLK, Vun YS, Chin KF, Chua R, Tambakau S, Binisol ES, Fernandez E, Singh N, Chan MKC, , 1987. The influence of permethrin-impregnated bednets and mass drug administration on the incidence of Plasmodium falciparum malaria in children in Sabah, Malaysia. Med Vet Entomol 1: 397407.[Crossref]
  39. Doi H, Kaneko A, Panjaitan W, Ishii A, , 1989. Chemotherapeutic malaria control operation by single dose of fandisar plus primaquine in North Sumatra, Indonesia. Southeast Asian J Trop Med Public Health 20: 341349.
  40. White NJ, Dondorp A, , 2013. Defining the Micro-Epidemiology and Elimination Strategy of Falciparum Malaria in Areas of Artemisinin Resistance (TME). Verified July 2014 by University of Oxford. Available at: http://clinicaltrials.gov/show/NCT01872702.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0254
Loading
/content/journals/10.4269/ajtmh.14-0254
Loading

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 25 Apr 2014
  • Accepted : 23 Feb 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error